CLLS
USDCellectis S.A. American Depositary Shares
$3.580-0.010 (-0.279%)
Real-time Price
Healthcare
Biotechnology
France
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.590
High
$3.710
Low
$3.480
Volume
0.00M
Company Fundamentals
Market Cap
368.0M
Industry
Biotechnology
Country
France
Trading Stats
Avg Volume
0.13M
Exchange
NGM
Currency
USD
52-Week Range
Low $1.1Current $3.580High $5.48
Related News
GlobeNewswire
Cellectis to Present a Development Update for eti-cel at ASH 2025
Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes in r/r NHLPreclinical data demonstrated that combining eti-cel with
View more
GlobeNewswire
Cellectis to Report Third Quarter Financial Results on November 7, 2025
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies,
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.